TNFSF10 and esophageal squamous cell carcinoma: Combination treatment with TRAIL (70 and 35 ng/mL) and thapsigargin (0.3 and 0.6 μM) induced apoptosis and inhibited migration, invasion, and adhesion of ESCC cell lines (esophageal squamous cell carcinoma), demonstrating that this combination induces both apoptosis and inhibits metastasis [129].